Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-20

Clinical Trial Update: Ondansetron for Bipolar Disorder and Alcohol Use Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial update of ondansetron for bipolar disorder and alcohol use disorders; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Bipolar Disorder, Alcohol Use Disorder | Phase 4 | Status: COMPLETED | Results posted: 2020-07-20